Table 2.
The most common adverse events in patients treated with secukinumab.
| Adverse event | n (%) |
|---|---|
| Candida infections | 23 (10.4) |
| Vaginal | 9 (3.93) |
| Intertriginous | 9 (3.93) |
| Oropharyngeal | 4 (1.75) |
| Onychomycosis | 3 (1.31) |
| Erosio interdigitalis blastomycetica | 3 (1.31) |
| Fatigue | 17 (7.42) |
| Nasopharyngitis | 16 (6.99) |
| Paradoxical arthritis | 13 (5.68) |
| Bronchitis | 4 (1.75) |
| Arthralgia | 4 (1.75) |
| Pruritus | 3 (1.31) |
| Increase in weight | 3 (1.31) |